semaglutide and cardiovascular outcomes in obesity 2. Original Article: without Diabetes https://t.co/sHpHQFOGLu #Cardiology Real-World Cardiovascular Outcomes of Obesity

Injections will typically occur in a convenient location such as under the patients arm

Staying well-hydrated and following dietary guidance - like limiting foods rich in potassium - can also play a key role in keeping your levels in check.

Joseph Heart Institute in Portland, Oregon

F or safe and effective weight loss approaches, please consult a licensed medical provider

If your eating is tied to stress, habits, or emotions, those patterns do not just disappear

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet